Craft

Brainsway

Stock Price

$10

2024-10-29

Market Capitalization

$166.6 M

2024-10-29

Revenue

$52.2 M

FY, 2025

Brainsway Summary

Company Summary

Overview
Brainsway engages in the development and provision of technology solutions for non-invasive treatment of brain disorders. It offers deep transcranial magnetic stimulation systems for treating various conditions, including autism, Alzheimer's disease, bipolar disorders, chronic pains, depressive disorders, Parkinson's diseases, schizophrenia, smoking cessation, post-traumatic stress disorders, multiple sclerosis, obsessive-compulsive disorders, and stroke rehabilitation.
Type
Public
Status
Active
Founded
2003
HQ
Jerusalem, IL | view all locations
Website
http://www.brainsway.com
Cybersecurity rating
Sectors

Key People

  • Christopher R. von Jako

    Christopher R. von Jako, President and Chief Executive Officer (CEO)

  • Christopher Boyer

    Christopher Boyer, VP of Global Marketing

  • Scott Areglado

    Scott Areglado, Senior VP and Chief Financial Officer (CFO)

  • Amit Ginou

Operating MetricsView all

Patents (US)

16

FY, 2018

Patents (Foreign)

25

FY, 2018

Patent Applications

29

FY, 2018

LocationsView all

2 locations detected

  • Jerusalem, Jerusalem District HQ

    Israel

    Hartom St 19

  • Cresskill, NJ

    United States

    300 Knickerbocker Rd #2300

Brainsway Financials

Summary Financials

Revenue (FY, 2025)
$52.2M
Gross profit (FY, 2025)
$40.5M
Net income (FY, 2025)
$7.6M
Cash (FY, 2025)
$67.7M
EBIT (FY, 2025)
$4.3M
Enterprise value
$114.7M

Footer menu